US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 4.010
  • +0.030+0.75%
Close Dec 20 16:00 ET
  • 4.090
  • +0.080+2.00%
Post 20:01 ET
255.86MMarket Cap-3.49P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Larimar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Larimar Therapeutics Earnings Reports

  • Larimar Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 31 05:07

  • Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results

    Oct 30 19:07

  • Larimar Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 02:44

  • Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results

    Aug 7 19:06

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data